Literature DB >> 21190259

Enhancement in MALDI-TOF MS analysis of the low molecular weight human serum proteome.

Christine L Gatlin, Krista Y White, Maureen B Tracy, Christopher E Wilkins, O John Semmes, Julius O Nyalwidhe, Richard R Drake, Dariya I Malyarenko.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21190259      PMCID： PMC3076319          DOI： 10.1002/jms.1864

Source DB:  PubMed          Journal:  J Mass Spectrom        ISSN： 1076-5174            Impact factor:   1.982


× No keyword cloud information.
  28 in total

1.  Composition of the peptide fraction in human blood plasma: database of circulating human peptides.

Authors:  R Richter; P Schulz-Knappe; M Schrader; L Ständker; M Jürgens; H Tammen; W G Forssmann
Journal:  J Chromatogr B Biomed Sci Appl       Date:  1999-04-16

Review 2.  Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations.

Authors:  Eleftherios P Diamandis
Journal:  Mol Cell Proteomics       Date:  2004-02-28       Impact factor: 5.911

3.  Analysis of Human Proteome Organization Plasma Proteome Project (HUPO PPP) reference specimens using surface enhanced laser desorption/ionization-time of flight (SELDI-TOF) mass spectrometry: multi-institution correlation of spectra and identification of biomarkers.

Authors:  Alex J Rai; Paul M Stemmer; Zhen Zhang; Bao-Ling Adam; William T Morgan; Rebecca E Caffrey; Vladimir N Podust; Manisha Patel; Lih-Yin Lim; Natalia V Shipulina; Daniel W Chan; O John Semmes; Hon-Chiu Eastwood Leung
Journal:  Proteomics       Date:  2005-08       Impact factor: 3.984

4.  Resampling and deconvolution of linear time-of-flight records for enhanced protein profiling.

Authors:  Dariya I Malyarenko; William E Cooke; Eugene R Tracy; Richard R Drake; Susanna Shin; O John Semmes; Maciek Sasinowski; Dennis M Manos
Journal:  Rapid Commun Mass Spectrom       Date:  2006       Impact factor: 2.419

5.  Enrichment of low molecular weight fraction of serum for MS analysis of peptides associated with hepatocellular carcinoma.

Authors:  Eduard Orvisky; Steven K Drake; Brian M Martin; Mohamed Abdel-Hamid; Habtom W Ressom; Rency S Varghese; Yanming An; Daniel Saha; Glen L Hortin; Christopher A Loffredo; Radoslav Goldman
Journal:  Proteomics       Date:  2006-05       Impact factor: 3.984

6.  Mass spectrometry: a tool for enhanced detection of hemoglobin variants.

Authors:  Peter Kleinert; Marlis Schmid; Karin Zurbriggen; Oliver Speer; Markus Schmugge; Bernd Roschitzki; Silke S Durka; Urs Leopold; Thomas Kuster; Claus W Heizmann; Hannes Frischknecht; Heinz Troxler
Journal:  Clin Chem       Date:  2007-10-11       Impact factor: 8.327

Review 7.  Reproducibility in protein profiling by MALDI-TOF mass spectrometry.

Authors:  Jakob Albrethsen
Journal:  Clin Chem       Date:  2007-03-29       Impact factor: 8.327

Review 8.  Serum protein profiling by solid phase extraction and mass spectrometry: a future diagnostics tool?

Authors:  Anne K Callesen; Jonna S Madsen; Werner Vach; Torben A Kruse; Ole Mogensen; Ole N Jensen
Journal:  Proteomics       Date:  2009-03       Impact factor: 3.984

9.  Three-layer matrix/sample preparation method for MALDI MS analysis of low nanomolar protein samples.

Authors:  Bernd O Keller; Liang Li
Journal:  J Am Soc Mass Spectrom       Date:  2006-04-03       Impact factor: 3.109

10.  Improved peptide mass fingerprinting matches via optimized sample preparation in MALDI mass spectrometry.

Authors:  Neerav D Padliya; Troy D Wood
Journal:  Anal Chim Acta       Date:  2008-06-12       Impact factor: 6.558
View more
  2 in total

1.  Improved signal processing and normalization for biomarker protein detection in broad-mass-range TOF mass spectra from clinical samples.

Authors:  Maureen B Tracy; William E Cooke; Christine L Gatlin; Lisa H Cazares; Dennis M Weaver; O John Semmes; Eugene R Tracy; Dennis M Manos; Dariya I Malyarenko
Journal:  Proteomics Clin Appl       Date:  2011-07-13       Impact factor: 3.494

2.  Prognostic accuracy of MALDI-TOF mass spectrometric analysis of plasma in COVID-19.

Authors:  Lucas Cardoso Lazari; Fabio De Rose Ghilardi; Livia Rosa-Fernandes; Diego M Assis; José Carlos Nicolau; Veronica Feijoli Santiago; Talia Falcão Dalçóquio; Claudia B Angeli; Adriadne Justi Bertolin; Claudio Rf Marinho; Carsten Wrenger; Edison Luiz Durigon; Rinaldo Focaccia Siciliano; Giuseppe Palmisano
Journal:  Life Sci Alliance       Date:  2021-06-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.